Clinical trial
Многоцентровое двойное слепое плацебо-контролируемое рандомизированное исследование препарата Рунихол® у пациентов с неалкогольной жировой болезнью печени на фоне метаболического синдрома
NCT02930161 is registered in ClinicalTrials.gov with POLYSAN Scientific & Technological Pharmaceutical Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Многоцентровое двойное слепое плацебо-контролируемое рандомизированное исследование препарата Рунихол® у пациентов с неалкогольной жировой болезнью печени на фоне метаболического синдрома
- Lead sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 30, 2016
- Completion date
- October 10, 2018
- Enrollment
- 35 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.